A Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose RoActemra/Actemra (Tocilizumab) in Healthy Volunteers

NCT01991990 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: placebo
DRUG: tocilizumab [RoActemra/Actemra]

Sponsor

Hoffmann-La Roche